Arrowstreet Capital
PGNX

Arrowstreet Capital’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Arrowstreet Capital’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-205,370
Closed -$780K – 2513
2020
Q1 		$780K Buy
+205,370
New +$780K ﹤0.01% 1394